Medicare Enrolled

Dr. Audrey Lewerenz-Walsh, DO

Family Medicine · Bradenton, FL
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Low-engagement
3007 MANATEE AVE W, Bradenton, FL 34205
9417488069
In practice since 2006 (20 years)
NPI: 1508846866 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Lewerenz-Walsh from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Lewerenz-Walsh? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Lewerenz-Walsh

Dr. Audrey Lewerenz-Walsh is a family medicine in Bradenton, FL, with 20 years in practice. Based on federal Medicare data, Dr. Lewerenz-Walsh performed 968 Medicare services across 400 unique beneficiaries.

Between the years covered by Open Payments, Dr. Lewerenz-Walsh received a total of $7,351 from 47 pharmaceutical and/or device companies across 373 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in family medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Lewerenz-Walsh is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice▲ Top 36% volume in FL$ $7,351 industry payments

Medicare Practice Summary

Medicare Utilization ↗
968
Medicare services
Top 36% in FL for family medicine
400
Unique beneficiaries
$72
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~48 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Office visit, established patient (30-39 min)591$90$360
Assessment of emotional or behavioral problems72$4$14
Chronic care management services for two or more chronic conditions, first 30 minutes provided personally by health care professional, per calendar month69$55$228
Annual depression screening47$18$51
Steroid injection (triamcinolone)47$1$5
Transitional care management services for problem of high complexity31$219$775
Smoking and tobacco use intensive counseling, 4-10 minutes28$15$43
Office visit, established patient, complex (40-54 min)20$143$505
Drug injection, under skin or into muscle18$11$39
Electrocardiogram (EKG), 12-lead16$7$41
Blood draw (venipuncture)15$8$14
Office visit, established patient (20-29 min)14$62$253
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$7,351
Total received (2018-2024)
Avg $1,050/year across 7 years
Top 7% in FL for family medicine
47
Companies
373
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$7,238 (98.5%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$112 (1.5%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,634
2023
$1,554
2022
$1,449
2021
$1,479
2020
$525
2019
$465
2018
$245

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Lilly USA, LLC
$823
Novo Nordisk Inc
$807
AstraZeneca Pharmaceuticals LP
$706
ABBVIE INC.
$685
Amgen Inc.
$592
GlaxoSmithKline, LLC.
$360
Teva Pharmaceuticals USA, Inc.
$292
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$223
PFIZER INC.
$216
IDORSIA PHARMACEUTICALS US INC
$208
Boehringer Ingelheim Pharmaceuticals, Inc.
$207
Abbott Laboratories
$169
Eisai Inc.
$161
Janssen Pharmaceuticals, Inc
$148
Astellas Pharma US Inc
$148
Novartis Pharmaceuticals Corporation
$143
Biohaven Pharmaceuticals, Inc.
$141
Takeda Pharmaceuticals U.S.A., Inc.
$99
Bayer Healthcare Pharmaceuticals Inc.
$93
BioDelivery Sciences International, Inc.
$89
Helsinn Therapeutics (U.S.), Inc.
$78
AbbVie Inc.
$72
RedHill Biopharma Inc.
$70
Exact Sciences Corporation
$69
Dexcom, Inc.
$62
Boston Scientific Corporation
$58
Corium, LLC
$56
IBSA Pharma Inc.
$50
Biohaven Pharmaceutical Holding Company Ltd.
$45
GRT US Holding, Inc.
$45
Emergent BioSolutions Inc.
$45
ViiV Healthcare Company
$40
Janssen Biotech, Inc.
$39
Sandoz Inc.
$35
ARBOR PHARMACEUTICALS, INC.
$35
Bayer HealthCare Pharmaceuticals Inc.
$33
Currax Pharmaceuticals LLC
$28
Inari Medical, Inc.
$25
GENZYME CORPORATION
$24
Otsuka America Pharmaceutical, Inc.
$20
E.R. Squibb & Sons, L.L.C.
$20
Merck Sharp & Dohme LLC
$19
Lundbeck LLC
$16
JAZZ PHARMACEUTICALS INC.
$15
Kowa Pharmaceuticals America, Inc.
$15
Paratek Pharmaceuticals, Inc.
$13
Bardy Diagnostics, Inc.
$12
Top 3 companies account for 31.8% of total payments
Associated products mentioned in payments ›
ADVAIR · AIRSUPRA · AJOVY · ANORO · ANORO ELLIPTA · APRETUDE · AUSTEDO · Aimovig · Azstarys · BASAGLAR · BELBUCA · BOTOX · BREO · BREZTRI · BYDUREON · CHANTIX · Carnation Ambulatory Monitor · Cologuard Collection Kit · Dayvigo · Dexcom G6 Transmitter · ELIQUIS · EMGALITY · ENTRESTO · EVENITY · FARXIGA · FLOWTRIEVER CATHETER · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · GARDASIL 9 · HYRIMOZ · Horizant · INVOKANA · JARDIANCE · Kerendia · LEQVIO · Leqembi · MOUNJARO · MOVANTIK · MYRBETRIQ · NURTEC ODT · NUZYRA · Narcan · ONZETRA XSAIL · Otezla · Ozempic · POMPE - DISEASE · Prolia · QULIPTA · QUVIVIQ · Qutenza · RELISTOR · REXULTI · REYVOW · RYBELSUS · Repatha · Rybelsus · S · SHINGRIX · SPIRIVA RESPIMAT · SPRAVATO · STIOLTO RESPIMAT · SUNOSI · SYMTUZA · Saxenda · TRELEGY ELLIPTA · TRINTELLIX · TRULICITY · Tirosint · Trintellix · UBRELVY · VALCHLOR · VRAYLAR · Veozah · Victoza · WATCHMAN · WATCHMAN Access System · Wegovy · XARELTO · XIFAXAN · ZEPBOUND · ZORYVE
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (98%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 7% for family medicine in FL.

Equivalent to $759 per 100 Medicare services performed
Looking for a family medicine in Bradenton?
Compare family medicines in the Bradenton area by procedure volume, costs, and industry payment transparency.
Browse family medicines nearby

Geographic Context

Family Medicines within 10 mi
519
Per 100K population
124.8
County median income
$75,792
Nearest hospital
SUNCOAST BEHAVIORAL HEALTH CENTER
4.2 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Lewerenz-Walsh is a clinical cardiology specialist, with moderate Medicare volume, and high industry engagement (low-engagement, top 7%), with 20 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Lewerenz-Walsh experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Lewerenz-Walsh performed 591 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Lewerenz-Walsh receive payments from pharmaceutical companies?
Yes. Dr. Lewerenz-Walsh received a total of $7,351 from 47 companies across 373 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Lewerenz-Walsh's costs compare to other family medicines in Bradenton?
Dr. Lewerenz-Walsh's average Medicare payment per service is $72. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Lewerenz-Walsh) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →